Home > Insider Trading > Filing (0001387131-18-002392)

Filing Details

Accession Number:: 0001387131-18-002392
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-25 18:31:04
Reporting Period:: 2018-05-24

Accepted Time:: 2018-05-25 18:31:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1528557	Corindus Vascular Robotics Inc.	CVRS	Surgical & Medical Instruments & Apparatus (3841)	300687898

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1700257	A Louis Cannon	309 Waverley Oaks Road, Suite 105 Waltham MA 02452		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-24	10,000	$0.80	82,955	No	4	P	Direct
Common Stock	Acquisiton	2018-05-25	6,500	$0.77	89,455	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,557,436	Indirect	See Footnote

Footnotes

Includes 9,174 shares of common stock related to restricted stock units granted as part of the director's annual equity award in 2017 which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date.
60,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein.
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8002 to $0.805, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7694 to $0.77, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
67,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.